nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—BCHE—Irinotecan—lung cancer	0.148	0.551	CbGbCtD
Procaine—BCHE—Cisplatin—lung cancer	0.12	0.449	CbGbCtD
Procaine—BCHE—diaphragm—lung cancer	0.0184	0.364	CbGeAlD
Procaine—CHRNA2—mammary gland—lung cancer	0.00796	0.157	CbGeAlD
Procaine—HTR3A—respiratory system—lung cancer	0.00379	0.0749	CbGeAlD
Procaine—SLC6A3—respiratory system—lung cancer	0.00316	0.0623	CbGeAlD
Procaine—Probenecid—ABCC3—lung cancer	0.00297	0.281	CrCbGaD
Procaine—SCN10A—lung—lung cancer	0.00217	0.0429	CbGeAlD
Procaine—BCHE—respiratory system—lung cancer	0.0021	0.0415	CbGeAlD
Procaine—HTR3A—lung—lung cancer	0.00201	0.0398	CbGeAlD
Procaine—Clomifene—CYP2A6—lung cancer	0.00182	0.172	CrCbGaD
Procaine—BCHE—bronchus—lung cancer	0.00173	0.0342	CbGeAlD
Procaine—SLC6A3—lung—lung cancer	0.00168	0.0331	CbGeAlD
Procaine—BCHE—trachea—lung cancer	0.00155	0.0307	CbGeAlD
Procaine—SCN10A—lymph node—lung cancer	0.00149	0.0293	CbGeAlD
Procaine—BCHE—cardiac atrium—lung cancer	0.00146	0.0288	CbGeAlD
Procaine—Clomifene—CYP2E1—lung cancer	0.00129	0.122	CrCbGaD
Procaine—Clomifene—CYP1A1—lung cancer	0.00127	0.12	CrCbGaD
Procaine—BCHE—bone marrow—lung cancer	0.00123	0.0244	CbGeAlD
Procaine—BCHE—lung—lung cancer	0.00112	0.0221	CbGeAlD
Procaine—Nausea—Teniposide—lung cancer	0.000821	0.002	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—lung cancer	0.000821	0.002	CcSEcCtD
Procaine—Hypotension—Vinorelbine—lung cancer	0.000819	0.00199	CcSEcCtD
Procaine—Urticaria—Topotecan—lung cancer	0.000814	0.00198	CcSEcCtD
Procaine—Body temperature increased—Topotecan—lung cancer	0.00081	0.00197	CcSEcCtD
Procaine—Erythema—Cisplatin—lung cancer	0.000804	0.00196	CcSEcCtD
Procaine—Body temperature increased—Erlotinib—lung cancer	0.000801	0.00195	CcSEcCtD
Procaine—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000798	0.00194	CcSEcCtD
Procaine—Syncope—Irinotecan—lung cancer	0.000794	0.00193	CcSEcCtD
Procaine—Leukopenia—Irinotecan—lung cancer	0.000793	0.00193	CcSEcCtD
Procaine—Loss of consciousness—Irinotecan—lung cancer	0.000778	0.00189	CcSEcCtD
Procaine—Hypersensitivity—Vinblastine—lung cancer	0.000777	0.00189	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000776	0.00189	CcSEcCtD
Procaine—Tinnitus—Paclitaxel—lung cancer	0.000774	0.00188	CcSEcCtD
Procaine—Leukopenia—Gemcitabine—lung cancer	0.000772	0.00188	CcSEcCtD
Procaine—Neuropathy peripheral—Docetaxel—lung cancer	0.000768	0.00187	CcSEcCtD
Procaine—Hypertension—Irinotecan—lung cancer	0.000765	0.00186	CcSEcCtD
Procaine—BCHE—lymph node—lung cancer	0.000764	0.0151	CbGeAlD
Procaine—Chills—Etoposide—lung cancer	0.000759	0.00185	CcSEcCtD
Procaine—Vision blurred—Cisplatin—lung cancer	0.000758	0.00184	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000757	0.00184	CcSEcCtD
Procaine—Fatigue—Vinorelbine—lung cancer	0.000756	0.00184	CcSEcCtD
Procaine—Hypersensitivity—Topotecan—lung cancer	0.000755	0.00184	CcSEcCtD
Procaine—Tremor—Cisplatin—lung cancer	0.000753	0.00183	CcSEcCtD
Procaine—Hypertension—Gemcitabine—lung cancer	0.000745	0.00181	CcSEcCtD
Procaine—Chills—Paclitaxel—lung cancer	0.000744	0.00181	CcSEcCtD
Procaine—Arthralgia—Gemcitabine—lung cancer	0.000734	0.00179	CcSEcCtD
Procaine—Pruritus—Topotecan—lung cancer	0.000725	0.00176	CcSEcCtD
Procaine—Anaphylactic shock—Irinotecan—lung cancer	0.000723	0.00176	CcSEcCtD
Procaine—Oedema—Irinotecan—lung cancer	0.000723	0.00176	CcSEcCtD
Procaine—Erythema—Paclitaxel—lung cancer	0.000722	0.00176	CcSEcCtD
Procaine—Diarrhoea—Vinblastine—lung cancer	0.000721	0.00176	CcSEcCtD
Procaine—Leukopenia—Cisplatin—lung cancer	0.00072	0.00175	CcSEcCtD
Procaine—Pruritus—Erlotinib—lung cancer	0.000717	0.00175	CcSEcCtD
Procaine—Shock—Irinotecan—lung cancer	0.000711	0.00173	CcSEcCtD
Procaine—Tension—Paclitaxel—lung cancer	0.000709	0.00173	CcSEcCtD
Procaine—Benzocaine—ABCB1—lung cancer	0.000708	0.0671	CrCbGaD
Procaine—Thrombocytopenia—Irinotecan—lung cancer	0.000708	0.00172	CcSEcCtD
Procaine—Anaphylactic shock—Gemcitabine—lung cancer	0.000704	0.00171	CcSEcCtD
Procaine—Oedema—Gemcitabine—lung cancer	0.000704	0.00171	CcSEcCtD
Procaine—Nervousness—Paclitaxel—lung cancer	0.000701	0.00171	CcSEcCtD
Procaine—Diarrhoea—Topotecan—lung cancer	0.000701	0.00171	CcSEcCtD
Procaine—Hyperhidrosis—Irinotecan—lung cancer	0.000699	0.0017	CcSEcCtD
Procaine—Dizziness—Vinblastine—lung cancer	0.000697	0.0017	CcSEcCtD
Procaine—Convulsion—Cisplatin—lung cancer	0.000697	0.0017	CcSEcCtD
Procaine—Urticaria—Vinorelbine—lung cancer	0.000696	0.00169	CcSEcCtD
Procaine—Diarrhoea—Erlotinib—lung cancer	0.000693	0.00169	CcSEcCtD
Procaine—Body temperature increased—Vinorelbine—lung cancer	0.000693	0.00169	CcSEcCtD
Procaine—Thrombocytopenia—Gemcitabine—lung cancer	0.000689	0.00168	CcSEcCtD
Procaine—Anxiety—Cisplatin—lung cancer	0.000682	0.00166	CcSEcCtD
Procaine—Vision blurred—Paclitaxel—lung cancer	0.000681	0.00166	CcSEcCtD
Procaine—Hyperhidrosis—Gemcitabine—lung cancer	0.000681	0.00166	CcSEcCtD
Procaine—Dizziness—Topotecan—lung cancer	0.000677	0.00165	CcSEcCtD
Procaine—Tremor—Paclitaxel—lung cancer	0.000677	0.00165	CcSEcCtD
Procaine—Clomifene—ABCB1—lung cancer	0.000676	0.064	CrCbGaD
Procaine—Hypotension—Irinotecan—lung cancer	0.000675	0.00164	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—AVP—lung cancer	0.000673	0.00259	CbGpPWpGaD
Procaine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000672	0.00164	CcSEcCtD
Procaine—Vomiting—Vinblastine—lung cancer	0.00067	0.00163	CcSEcCtD
Procaine—Dizziness—Erlotinib—lung cancer	0.00067	0.00163	CcSEcCtD
Procaine—Agitation—Paclitaxel—lung cancer	0.000664	0.00162	CcSEcCtD
Procaine—Angioedema—Paclitaxel—lung cancer	0.00066	0.00161	CcSEcCtD
Procaine—Leukopenia—Etoposide—lung cancer	0.000659	0.00161	CcSEcCtD
Procaine—Hypotension—Gemcitabine—lung cancer	0.000658	0.0016	CcSEcCtD
Procaine—Anaphylactic shock—Cisplatin—lung cancer	0.000656	0.0016	CcSEcCtD
Procaine—Oedema—Cisplatin—lung cancer	0.000656	0.0016	CcSEcCtD
Procaine—SCN10A—Developmental Biology—SLIT2—lung cancer	0.000655	0.00252	CbGpPWpGaD
Procaine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000655	0.0016	CcSEcCtD
Procaine—Vomiting—Topotecan—lung cancer	0.000651	0.00159	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—GSTA1—lung cancer	0.000649	0.0025	CbGpPWpGaD
Procaine—Syncope—Paclitaxel—lung cancer	0.000648	0.00158	CcSEcCtD
Procaine—Loss of consciousness—Etoposide—lung cancer	0.000647	0.00158	CcSEcCtD
Procaine—Leukopenia—Paclitaxel—lung cancer	0.000646	0.00157	CcSEcCtD
Procaine—Rash—Topotecan—lung cancer	0.000646	0.00157	CcSEcCtD
Procaine—Hypersensitivity—Vinorelbine—lung cancer	0.000646	0.00157	CcSEcCtD
Procaine—Dermatitis—Topotecan—lung cancer	0.000645	0.00157	CcSEcCtD
Procaine—Vomiting—Erlotinib—lung cancer	0.000644	0.00157	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000643	0.00248	CbGpPWpGaD
Procaine—Somnolence—Irinotecan—lung cancer	0.000643	0.00156	CcSEcCtD
Procaine—Thrombocytopenia—Cisplatin—lung cancer	0.000642	0.00156	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—ABCC3—lung cancer	0.000642	0.00247	CbGpPWpGaD
Procaine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000641	0.00156	CcSEcCtD
Procaine—Tachycardia—Cisplatin—lung cancer	0.00064	0.00156	CcSEcCtD
Procaine—CHRNA2—Neuronal System—GNG11—lung cancer	0.00064	0.00246	CbGpPWpGaD
Procaine—Rash—Erlotinib—lung cancer	0.000639	0.00156	CcSEcCtD
Procaine—Dermatitis—Erlotinib—lung cancer	0.000638	0.00155	CcSEcCtD
Procaine—Convulsion—Etoposide—lung cancer	0.000638	0.00155	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—HES1—lung cancer	0.000636	0.00245	CbGpPWpGaD
Procaine—Hypertension—Etoposide—lung cancer	0.000636	0.00155	CcSEcCtD
Procaine—Loss of consciousness—Paclitaxel—lung cancer	0.000635	0.00155	CcSEcCtD
Procaine—Hyperhidrosis—Cisplatin—lung cancer	0.000634	0.00154	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL10—lung cancer	0.000633	0.00243	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.000632	0.00243	CbGpPWpGaD
Procaine—Chills—Docetaxel—lung cancer	0.000631	0.00154	CcSEcCtD
Procaine—Probenecid—ALB—lung cancer	0.000629	0.0596	CrCbGaD
Procaine—Eosinophilia—Methotrexate—lung cancer	0.000627	0.00153	CcSEcCtD
Procaine—Nausea—Vinblastine—lung cancer	0.000626	0.00152	CcSEcCtD
Procaine—Somnolence—Gemcitabine—lung cancer	0.000626	0.00152	CcSEcCtD
Procaine—Convulsion—Paclitaxel—lung cancer	0.000626	0.00152	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—MAP2K1—lung cancer	0.000624	0.0024	CbGpPWpGaD
Procaine—Hypertension—Paclitaxel—lung cancer	0.000624	0.00152	CcSEcCtD
Procaine—Fatigue—Irinotecan—lung cancer	0.000623	0.00152	CcSEcCtD
Procaine—Pruritus—Vinorelbine—lung cancer	0.00062	0.00151	CcSEcCtD
Procaine—Arthralgia—Paclitaxel—lung cancer	0.000615	0.0015	CcSEcCtD
Procaine—Hypotension—Cisplatin—lung cancer	0.000613	0.00149	CcSEcCtD
Procaine—Anxiety—Paclitaxel—lung cancer	0.000613	0.00149	CcSEcCtD
Procaine—Erythema—Docetaxel—lung cancer	0.000612	0.00149	CcSEcCtD
Procaine—SCN10A—Developmental Biology—NODAL—lung cancer	0.000609	0.00234	CbGpPWpGaD
Procaine—Nausea—Topotecan—lung cancer	0.000608	0.00148	CcSEcCtD
Procaine—Fatigue—Gemcitabine—lung cancer	0.000607	0.00148	CcSEcCtD
Procaine—BCHE—Neuronal System—GRIK3—lung cancer	0.000605	0.00233	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—UGT1A1—lung cancer	0.000604	0.00232	CbGpPWpGaD
Procaine—Cardiac arrest—Doxorubicin—lung cancer	0.000603	0.00147	CcSEcCtD
Procaine—Nausea—Erlotinib—lung cancer	0.000602	0.00147	CcSEcCtD
Procaine—Anaphylactic shock—Etoposide—lung cancer	0.000601	0.00146	CcSEcCtD
Procaine—Probenecid—ABCB1—lung cancer	0.000601	0.0569	CrCbGaD
Procaine—Diarrhoea—Vinorelbine—lung cancer	0.0006	0.00146	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000598	0.0023	CbGpPWpGaD
Procaine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000598	0.00146	CcSEcCtD
Procaine—SLC6A3—Neuronal System—GRIK3—lung cancer	0.000594	0.00228	CbGpPWpGaD
Procaine—Aminohippurate—ABCB1—lung cancer	0.000593	0.0561	CrCbGaD
Procaine—SCN10A—Axon guidance—NCAM1—lung cancer	0.000592	0.00228	CbGpPWpGaD
Procaine—Oedema—Paclitaxel—lung cancer	0.000589	0.00143	CcSEcCtD
Procaine—Anaphylactic shock—Paclitaxel—lung cancer	0.000589	0.00143	CcSEcCtD
Procaine—Thrombocytopenia—Etoposide—lung cancer	0.000589	0.00143	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.000587	0.00226	CbGpPWpGaD
Procaine—Tachycardia—Etoposide—lung cancer	0.000587	0.00143	CcSEcCtD
Procaine—Hyperhidrosis—Etoposide—lung cancer	0.000581	0.00141	CcSEcCtD
Procaine—Shock—Paclitaxel—lung cancer	0.00058	0.00141	CcSEcCtD
Procaine—Dizziness—Vinorelbine—lung cancer	0.000579	0.00141	CcSEcCtD
Procaine—Thrombocytopenia—Paclitaxel—lung cancer	0.000577	0.0014	CcSEcCtD
Procaine—CHRNA2—Neuronal System—ADCY1—lung cancer	0.000576	0.00222	CbGpPWpGaD
Procaine—Tachycardia—Paclitaxel—lung cancer	0.000575	0.0014	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—NFE2L2—lung cancer	0.000572	0.0022	CbGpPWpGaD
Procaine—Body temperature increased—Irinotecan—lung cancer	0.000571	0.00139	CcSEcCtD
Procaine—Hyperhidrosis—Paclitaxel—lung cancer	0.00057	0.00139	CcSEcCtD
Procaine—Drowsiness—Methotrexate—lung cancer	0.000565	0.00137	CcSEcCtD
Procaine—Hypotension—Etoposide—lung cancer	0.000562	0.00137	CcSEcCtD
Procaine—Vomiting—Vinorelbine—lung cancer	0.000557	0.00136	CcSEcCtD
Procaine—Body temperature increased—Gemcitabine—lung cancer	0.000557	0.00135	CcSEcCtD
Procaine—Rash—Vinorelbine—lung cancer	0.000553	0.00135	CcSEcCtD
Procaine—Dermatitis—Vinorelbine—lung cancer	0.000552	0.00134	CcSEcCtD
Procaine—Hypotension—Paclitaxel—lung cancer	0.000551	0.00134	CcSEcCtD
Procaine—Syncope—Docetaxel—lung cancer	0.000549	0.00134	CcSEcCtD
Procaine—Leukopenia—Docetaxel—lung cancer	0.000548	0.00133	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—TGFA—lung cancer	0.000546	0.0021	CbGpPWpGaD
Procaine—Eosinophilia—Doxorubicin—lung cancer	0.000543	0.00132	CcSEcCtD
Procaine—Loss of consciousness—Docetaxel—lung cancer	0.000538	0.00131	CcSEcCtD
Procaine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000537	0.00131	CcSEcCtD
Procaine—Somnolence—Etoposide—lung cancer	0.000534	0.0013	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000533	0.00205	CbGpPWpGaD
Procaine—Hypersensitivity—Irinotecan—lung cancer	0.000532	0.0013	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000531	0.00204	CbGpPWpGaD
Procaine—Convulsion—Docetaxel—lung cancer	0.00053	0.00129	CcSEcCtD
Procaine—Hypertension—Docetaxel—lung cancer	0.000529	0.00129	CcSEcCtD
Procaine—Somnolence—Paclitaxel—lung cancer	0.000524	0.00128	CcSEcCtD
Procaine—Arthralgia—Docetaxel—lung cancer	0.000521	0.00127	CcSEcCtD
Procaine—Nausea—Vinorelbine—lung cancer	0.000521	0.00127	CcSEcCtD
Procaine—Body temperature increased—Cisplatin—lung cancer	0.000519	0.00126	CcSEcCtD
Procaine—Fatigue—Etoposide—lung cancer	0.000518	0.00126	CcSEcCtD
Procaine—Fatigue—Paclitaxel—lung cancer	0.000508	0.00124	CcSEcCtD
Procaine—Anaphylactic shock—Docetaxel—lung cancer	0.0005	0.00122	CcSEcCtD
Procaine—Oedema—Docetaxel—lung cancer	0.0005	0.00122	CcSEcCtD
Procaine—SLC6A3—Alpha-synuclein signaling—SRC—lung cancer	0.0005	0.00192	CbGpPWpGaD
Procaine—Pruritus—Gemcitabine—lung cancer	0.000498	0.00121	CcSEcCtD
Procaine—SLC6A3—Dopaminergic Neurogenesis—STAT3—lung cancer	0.000495	0.0019	CbGpPWpGaD
Procaine—Diarrhoea—Irinotecan—lung cancer	0.000494	0.0012	CcSEcCtD
Procaine—BCHE—Neuronal System—CHRNB4—lung cancer	0.000493	0.0019	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GCLC—lung cancer	0.000492	0.00189	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—CYP2A6—lung cancer	0.000492	0.00189	CbGpPWpGaD
Procaine—Shock—Docetaxel—lung cancer	0.000492	0.0012	CcSEcCtD
Procaine—Thrombocytopenia—Docetaxel—lung cancer	0.000489	0.00119	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—lung cancer	0.000489	0.00119	CcSEcCtD
Procaine—Tachycardia—Docetaxel—lung cancer	0.000488	0.00119	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000488	0.00188	CbGpPWpGaD
Procaine—SLC6A3—Parkinsons Disease Pathway—CASP3—lung cancer	0.000487	0.00187	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CHRNB4—lung cancer	0.000484	0.00186	CbGpPWpGaD
Procaine—Hypersensitivity—Cisplatin—lung cancer	0.000483	0.00118	CcSEcCtD
Procaine—Diarrhoea—Gemcitabine—lung cancer	0.000482	0.00117	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000479	0.00117	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000479	0.00184	CbGpPWpGaD
Procaine—Dizziness—Irinotecan—lung cancer	0.000478	0.00116	CcSEcCtD
Procaine—Urticaria—Etoposide—lung cancer	0.000478	0.00116	CcSEcCtD
Procaine—Body temperature increased—Etoposide—lung cancer	0.000475	0.00116	CcSEcCtD
Procaine—Tinnitus—Methotrexate—lung cancer	0.000473	0.00115	CcSEcCtD
Procaine—Urticaria—Paclitaxel—lung cancer	0.000468	0.00114	CcSEcCtD
Procaine—Hypotension—Docetaxel—lung cancer	0.000467	0.00114	CcSEcCtD
Procaine—Body temperature increased—Paclitaxel—lung cancer	0.000466	0.00113	CcSEcCtD
Procaine—SCN10A—Developmental Biology—SOX2—lung cancer	0.000462	0.00178	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—GNG11—lung cancer	0.000461	0.00177	CbGpPWpGaD
Procaine—Vomiting—Irinotecan—lung cancer	0.00046	0.00112	CcSEcCtD
Procaine—BCHE—Neuronal System—CHRNA5—lung cancer	0.000458	0.00176	CbGpPWpGaD
Procaine—Rash—Irinotecan—lung cancer	0.000456	0.00111	CcSEcCtD
Procaine—Dermatitis—Irinotecan—lung cancer	0.000455	0.00111	CcSEcCtD
Procaine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000455	0.00111	CcSEcCtD
Procaine—Chills—Methotrexate—lung cancer	0.000455	0.00111	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000453	0.00174	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—GNG11—lung cancer	0.000453	0.00174	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CHRNA5—lung cancer	0.00045	0.00173	CbGpPWpGaD
Procaine—Diarrhoea—Cisplatin—lung cancer	0.000449	0.00109	CcSEcCtD
Procaine—Vomiting—Gemcitabine—lung cancer	0.000448	0.00109	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—lung cancer	0.000447	0.00109	CcSEcCtD
Procaine—Somnolence—Docetaxel—lung cancer	0.000444	0.00108	CcSEcCtD
Procaine—Rash—Gemcitabine—lung cancer	0.000444	0.00108	CcSEcCtD
Procaine—Dermatitis—Gemcitabine—lung cancer	0.000443	0.00108	CcSEcCtD
Procaine—Hypersensitivity—Etoposide—lung cancer	0.000443	0.00108	CcSEcCtD
Procaine—Erythema—Methotrexate—lung cancer	0.000441	0.00107	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000436	0.00168	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000436	0.00168	CbGpPWpGaD
Procaine—Hypersensitivity—Paclitaxel—lung cancer	0.000434	0.00106	CcSEcCtD
Procaine—SCN10A—Developmental Biology—NCOA3—lung cancer	0.000434	0.00167	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—SRC—lung cancer	0.000433	0.00166	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000433	0.00166	CbGpPWpGaD
Procaine—Fatigue—Docetaxel—lung cancer	0.000431	0.00105	CcSEcCtD
Procaine—Nausea—Irinotecan—lung cancer	0.000429	0.00105	CcSEcCtD
Procaine—Pruritus—Etoposide—lung cancer	0.000425	0.00104	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000423	0.00163	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NCAM1—lung cancer	0.000422	0.00163	CbGpPWpGaD
Procaine—Nausea—Gemcitabine—lung cancer	0.000418	0.00102	CcSEcCtD
Procaine—Vomiting—Cisplatin—lung cancer	0.000417	0.00102	CcSEcCtD
Procaine—Pruritus—Paclitaxel—lung cancer	0.000417	0.00102	CcSEcCtD
Procaine—Vision blurred—Methotrexate—lung cancer	0.000416	0.00101	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000415	0.0016	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—NQO1—lung cancer	0.000414	0.00159	CbGpPWpGaD
Procaine—Rash—Cisplatin—lung cancer	0.000414	0.00101	CcSEcCtD
Procaine—Dermatitis—Cisplatin—lung cancer	0.000413	0.00101	CcSEcCtD
Procaine—Diarrhoea—Etoposide—lung cancer	0.000411	0.001	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—lung cancer	0.000409	0.000996	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000407	0.00157	CbGpPWpGaD
Procaine—Diarrhoea—Paclitaxel—lung cancer	0.000403	0.000982	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000402	0.00155	CbGpPWpGaD
Procaine—SCN10A—L1CAM interactions—MAPK3—lung cancer	0.000399	0.00153	CbGpPWpGaD
Procaine—Dizziness—Etoposide—lung cancer	0.000398	0.000968	CcSEcCtD
Procaine—Body temperature increased—Docetaxel—lung cancer	0.000395	0.000961	CcSEcCtD
Procaine—Leukopenia—Methotrexate—lung cancer	0.000395	0.000961	CcSEcCtD
Procaine—Chills—Doxorubicin—lung cancer	0.000394	0.000959	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—GNG11—lung cancer	0.000392	0.00151	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—ITGB1—lung cancer	0.000392	0.00151	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—EIF2B4—lung cancer	0.00039	0.0015	CbGpPWpGaD
Procaine—Dizziness—Paclitaxel—lung cancer	0.00039	0.000949	CcSEcCtD
Procaine—Nausea—Cisplatin—lung cancer	0.00039	0.000949	CcSEcCtD
Procaine—Convulsion—Methotrexate—lung cancer	0.000382	0.000931	CcSEcCtD
Procaine—Vomiting—Etoposide—lung cancer	0.000382	0.00093	CcSEcCtD
Procaine—Erythema—Doxorubicin—lung cancer	0.000382	0.00093	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—EGFR—lung cancer	0.000379	0.00146	CbGpPWpGaD
Procaine—Rash—Etoposide—lung cancer	0.000379	0.000923	CcSEcCtD
Procaine—Dermatitis—Etoposide—lung cancer	0.000379	0.000922	CcSEcCtD
Procaine—Arthralgia—Methotrexate—lung cancer	0.000376	0.000914	CcSEcCtD
Procaine—Tension—Doxorubicin—lung cancer	0.000375	0.000913	CcSEcCtD
Procaine—Vomiting—Paclitaxel—lung cancer	0.000375	0.000912	CcSEcCtD
Procaine—BCHE—Neuronal System—CHRNA3—lung cancer	0.000374	0.00144	CbGpPWpGaD
Procaine—Rash—Paclitaxel—lung cancer	0.000372	0.000905	CcSEcCtD
Procaine—Dermatitis—Paclitaxel—lung cancer	0.000371	0.000904	CcSEcCtD
Procaine—Nervousness—Doxorubicin—lung cancer	0.000371	0.000903	CcSEcCtD
Procaine—Hypersensitivity—Docetaxel—lung cancer	0.000368	0.000896	CcSEcCtD
Procaine—SLC6A3—Neuronal System—CHRNA3—lung cancer	0.000367	0.00141	CbGpPWpGaD
Procaine—Anaphylactic shock—Methotrexate—lung cancer	0.00036	0.000877	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—lung cancer	0.00036	0.000876	CcSEcCtD
Procaine—HTR3A—Ion channel transport—RAF1—lung cancer	0.000358	0.00138	CbGpPWpGaD
Procaine—Nausea—Etoposide—lung cancer	0.000357	0.000869	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000354	0.00136	CbGpPWpGaD
Procaine—Pruritus—Docetaxel—lung cancer	0.000353	0.00086	CcSEcCtD
Procaine—BCHE—Neuronal System—GNG11—lung cancer	0.000353	0.00136	CbGpPWpGaD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000353	0.00136	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000353	0.00136	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000353	0.00136	CbGpPWpGaD
Procaine—Thrombocytopenia—Methotrexate—lung cancer	0.000353	0.000858	CcSEcCtD
Procaine—BCHE—Peptide hormone metabolism—POMC—lung cancer	0.000352	0.00135	CbGpPWpGaD
Procaine—Agitation—Doxorubicin—lung cancer	0.000351	0.000855	CcSEcCtD
Procaine—Nausea—Paclitaxel—lung cancer	0.00035	0.000852	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—lung cancer	0.000348	0.000847	CcSEcCtD
Procaine—SLC6A3—Neuronal System—GNG11—lung cancer	0.000347	0.00133	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000346	0.00133	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GSTP1—lung cancer	0.000345	0.00133	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000343	0.00132	CbGpPWpGaD
Procaine—Syncope—Doxorubicin—lung cancer	0.000343	0.000834	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—lung cancer	0.000342	0.000832	CcSEcCtD
Procaine—Diarrhoea—Docetaxel—lung cancer	0.000342	0.000832	CcSEcCtD
Procaine—Hypotension—Methotrexate—lung cancer	0.000336	0.000819	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—lung cancer	0.000336	0.000817	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000331	0.00127	CbGpPWpGaD
Procaine—Convulsion—Doxorubicin—lung cancer	0.000331	0.000806	CcSEcCtD
Procaine—Dizziness—Docetaxel—lung cancer	0.00033	0.000804	CcSEcCtD
Procaine—Hypertension—Doxorubicin—lung cancer	0.00033	0.000803	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000328	0.000799	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—TF—lung cancer	0.000328	0.00126	CbGpPWpGaD
Procaine—Arthralgia—Doxorubicin—lung cancer	0.000325	0.000792	CcSEcCtD
Procaine—Anxiety—Doxorubicin—lung cancer	0.000324	0.000789	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—JUN—lung cancer	0.000322	0.00124	CbGpPWpGaD
Procaine—Somnolence—Methotrexate—lung cancer	0.00032	0.000779	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—KHSRP—lung cancer	0.000318	0.00122	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—BRAF—lung cancer	0.000318	0.00122	CbGpPWpGaD
Procaine—BCHE—Neuronal System—ADCY1—lung cancer	0.000318	0.00122	CbGpPWpGaD
Procaine—Vomiting—Docetaxel—lung cancer	0.000318	0.000773	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—GSTM1—lung cancer	0.000317	0.00122	CbGpPWpGaD
Procaine—Rash—Docetaxel—lung cancer	0.000315	0.000767	CcSEcCtD
Procaine—Dermatitis—Docetaxel—lung cancer	0.000315	0.000766	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000313	0.0012	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—ADCY1—lung cancer	0.000312	0.0012	CbGpPWpGaD
Procaine—Oedema—Doxorubicin—lung cancer	0.000312	0.000759	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—lung cancer	0.000312	0.000759	CcSEcCtD
Procaine—Fatigue—Methotrexate—lung cancer	0.00031	0.000756	CcSEcCtD
Procaine—SCN10A—Axon guidance—FGFR1—lung cancer	0.000307	0.00118	CbGpPWpGaD
Procaine—Shock—Doxorubicin—lung cancer	0.000307	0.000747	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—KIF5B—lung cancer	0.000306	0.00118	CbGpPWpGaD
Procaine—Thrombocytopenia—Doxorubicin—lung cancer	0.000305	0.000743	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—lung cancer	0.000304	0.000741	CcSEcCtD
Procaine—Hyperhidrosis—Doxorubicin—lung cancer	0.000301	0.000734	CcSEcCtD
Procaine—Nausea—Docetaxel—lung cancer	0.000297	0.000722	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—EP300—lung cancer	0.000297	0.00114	CbGpPWpGaD
Procaine—Hypotension—Doxorubicin—lung cancer	0.000291	0.000709	CcSEcCtD
Procaine—SCN10A—Developmental Biology—FOXO3—lung cancer	0.00029	0.00112	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—KDR—lung cancer	0.000289	0.00111	CbGpPWpGaD
Procaine—Urticaria—Methotrexate—lung cancer	0.000286	0.000696	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—lung cancer	0.000285	0.000693	CcSEcCtD
Procaine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000284	0.000692	CcSEcCtD
Procaine—SCN10A—Axon guidance—MET—lung cancer	0.000283	0.00109	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000281	0.00108	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ITGB1—lung cancer	0.00028	0.00108	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—EIF2B5—lung cancer	0.000278	0.00107	CbGpPWpGaD
Procaine—Somnolence—Doxorubicin—lung cancer	0.000277	0.000675	CcSEcCtD
Procaine—Fatigue—Doxorubicin—lung cancer	0.000269	0.000654	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—MDM2—lung cancer	0.000266	0.00102	CbGpPWpGaD
Procaine—Hypersensitivity—Methotrexate—lung cancer	0.000265	0.000646	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—RAF1—lung cancer	0.000265	0.00102	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—HES1—lung cancer	0.000257	0.00099	CbGpPWpGaD
Procaine—Pruritus—Methotrexate—lung cancer	0.000255	0.00062	CcSEcCtD
Procaine—BCHE—Phospholipid metabolism—PIK3CG—lung cancer	0.000251	0.000966	CbGpPWpGaD
Procaine—Urticaria—Doxorubicin—lung cancer	0.000248	0.000603	CcSEcCtD
Procaine—SCN10A—Axon guidance—IL6R—lung cancer	0.000247	0.000951	CbGpPWpGaD
Procaine—Body temperature increased—Doxorubicin—lung cancer	0.000246	0.0006	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—lung cancer	0.000246	0.0006	CcSEcCtD
Procaine—CHRNA2—Neuronal System—BRAF—lung cancer	0.000243	0.000937	CbGpPWpGaD
Procaine—Dizziness—Methotrexate—lung cancer	0.000238	0.00058	CcSEcCtD
Procaine—BCHE—Metabolism—COL4A3BP—lung cancer	0.000236	0.000909	CbGpPWpGaD
Procaine—BCHE—Metabolism—AZIN2—lung cancer	0.000236	0.000909	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ST3GAL5—lung cancer	0.000236	0.000909	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MMP2—lung cancer	0.000236	0.000908	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MAP2K1—lung cancer	0.000236	0.000907	CbGpPWpGaD
Procaine—Hypersensitivity—Doxorubicin—lung cancer	0.00023	0.000559	CcSEcCtD
Procaine—Vomiting—Methotrexate—lung cancer	0.000229	0.000557	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—AVP—lung cancer	0.000227	0.000874	CbGpPWpGaD
Procaine—Rash—Methotrexate—lung cancer	0.000227	0.000553	CcSEcCtD
Procaine—Dermatitis—Methotrexate—lung cancer	0.000227	0.000552	CcSEcCtD
Procaine—BCHE—Phospholipid metabolism—PIK3CD—lung cancer	0.000221	0.000849	CbGpPWpGaD
Procaine—Pruritus—Doxorubicin—lung cancer	0.000221	0.000537	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.00022	0.000848	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ABCB1—lung cancer	0.00022	0.000847	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—FGFR1—lung cancer	0.000219	0.000843	CbGpPWpGaD
Procaine—Nausea—Methotrexate—lung cancer	0.000214	0.000521	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000213	0.000821	CbGpPWpGaD
Procaine—Diarrhoea—Doxorubicin—lung cancer	0.000213	0.000519	CcSEcCtD
Procaine—SLC6A3—SLC-mediated transmembrane transport—AVP—lung cancer	0.000213	0.000818	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—B4GALT5—lung cancer	0.000211	0.00081	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ADAMTS1—lung cancer	0.000211	0.00081	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—RAF1—lung cancer	0.000209	0.000804	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—ERBB2—lung cancer	0.000207	0.000796	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—KDR—lung cancer	0.000206	0.000794	CbGpPWpGaD
Procaine—Dizziness—Doxorubicin—lung cancer	0.000206	0.000502	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000206	0.000791	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—MDM2—lung cancer	0.000204	0.000785	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—RAF1—lung cancer	0.000203	0.000782	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MET—lung cancer	0.000202	0.000777	CbGpPWpGaD
Procaine—BCHE—Metabolism—ATP5H—lung cancer	0.000201	0.000773	CbGpPWpGaD
Procaine—Vomiting—Doxorubicin—lung cancer	0.000198	0.000483	CcSEcCtD
Procaine—Rash—Doxorubicin—lung cancer	0.000197	0.000479	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—lung cancer	0.000196	0.000478	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000194	0.000748	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6—lung cancer	0.000194	0.000748	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CB—lung cancer	0.000192	0.00074	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—GNG11—lung cancer	0.000186	0.000717	CbGpPWpGaD
Procaine—Nausea—Doxorubicin—lung cancer	0.000185	0.000451	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000185	0.00071	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GRP—lung cancer	0.000184	0.000709	CbGpPWpGaD
Procaine—BCHE—Metabolism—PLBD1—lung cancer	0.000179	0.000689	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MMP9—lung cancer	0.000177	0.000682	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6R—lung cancer	0.000176	0.000679	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CREBBP—lung cancer	0.000176	0.000678	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000176	0.000678	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—BRAF—lung cancer	0.000175	0.000675	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—APOA1—lung cancer	0.000174	0.000669	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—BRAF—lung cancer	0.000172	0.000662	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MMP2—lung cancer	0.000168	0.000648	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MAP2K1—lung cancer	0.000168	0.000647	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000168	0.000645	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000168	0.000645	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PTEN—lung cancer	0.000166	0.000639	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSD17B10—lung cancer	0.000164	0.00063	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—SRC—lung cancer	0.000164	0.000629	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ATF3—lung cancer	0.000161	0.000618	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—VEGFA—lung cancer	0.000159	0.000613	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—NRAS—lung cancer	0.000157	0.000605	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TF—lung cancer	0.000156	0.0006	CbGpPWpGaD
Procaine—BCHE—Metabolism—CKB—lung cancer	0.000152	0.000586	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MAPK3—lung cancer	0.000151	0.00058	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—RAF1—lung cancer	0.000149	0.000574	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ERBB2—lung cancer	0.000148	0.000568	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000147	0.000566	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—MDM2—lung cancer	0.000147	0.000565	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—RAF1—lung cancer	0.000146	0.000563	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—HRAS—lung cancer	0.000146	0.000562	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LMNA—lung cancer	0.000144	0.000555	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—MDM2—lung cancer	0.000144	0.000555	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—RAF1—lung cancer	0.000144	0.000553	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—EGFR—lung cancer	0.000143	0.000551	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTM2—lung cancer	0.000143	0.000551	CbGpPWpGaD
Procaine—BCHE—Metabolism—CNDP2—lung cancer	0.000143	0.000551	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTMR3—lung cancer	0.000139	0.000536	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ALB—lung cancer	0.000138	0.00053	CbGpPWpGaD
Procaine—BCHE—Metabolism—PGAM1—lung cancer	0.000136	0.000522	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—KRAS—lung cancer	0.000135	0.000521	CbGpPWpGaD
Procaine—BCHE—Neuronal System—BRAF—lung cancer	0.000134	0.000517	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—BRAF—lung cancer	0.000132	0.000507	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP2A7—lung cancer	0.000129	0.000498	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—ALB—lung cancer	0.000129	0.000496	CbGpPWpGaD
Procaine—BCHE—Metabolism—SDC4—lung cancer	0.000127	0.000488	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MMP9—lung cancer	0.000127	0.000487	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—RAF1—lung cancer	0.000125	0.000479	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EP300—lung cancer	0.00012	0.000462	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3CA—lung cancer	0.000117	0.000451	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SRC—lung cancer	0.000117	0.000449	CbGpPWpGaD
Procaine—BCHE—Metabolism—RRM1—lung cancer	0.000115	0.000444	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTA3—lung cancer	0.000115	0.000444	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—HRAS—lung cancer	0.000115	0.000443	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—VEGFA—lung cancer	0.000114	0.000437	CbGpPWpGaD
Procaine—BCHE—Neuronal System—MDM2—lung cancer	0.000113	0.000433	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—STAT3—lung cancer	0.000113	0.000433	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NRAS—lung cancer	0.000112	0.000432	CbGpPWpGaD
Procaine—BCHE—Neuronal System—RAF1—lung cancer	0.000112	0.000432	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—HRAS—lung cancer	0.000112	0.000431	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—MDM2—lung cancer	0.00011	0.000425	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—IL6—lung cancer	0.00011	0.000424	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—RAF1—lung cancer	0.00011	0.000424	CbGpPWpGaD
Procaine—BCHE—Metabolism—B4GALT5—lung cancer	0.000109	0.000418	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—AVP—lung cancer	0.000108	0.000416	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MAPK3—lung cancer	0.000108	0.000414	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTA4—lung cancer	0.000106	0.000406	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000105	0.000403	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000103	0.000397	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTA2—lung cancer	0.000103	0.000396	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EGFR—lung cancer	0.000102	0.000393	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTA1—lung cancer	9.92e-05	0.000382	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCC3—lung cancer	9.81e-05	0.000378	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—KRAS—lung cancer	9.66e-05	0.000372	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKR1C1—lung cancer	9.5e-05	0.000366	CbGpPWpGaD
Procaine—BCHE—Metabolism—UGT1A1—lung cancer	9.23e-05	0.000355	CbGpPWpGaD
Procaine—BCHE—Metabolism—GNG11—lung cancer	8.9e-05	0.000342	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.85e-05	0.000341	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALDOA—lung cancer	8.47e-05	0.000326	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—APOA1—lung cancer	8.26e-05	0.000318	CbGpPWpGaD
Procaine—BCHE—Metabolism—NCOA3—lung cancer	8.22e-05	0.000316	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—HRAS—lung cancer	8.21e-05	0.000316	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.08e-05	0.000311	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—HRAS—lung cancer	8.06e-05	0.00031	CbGpPWpGaD
Procaine—BCHE—Metabolism—ADCY1—lung cancer	8e-05	0.000308	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCG2—lung cancer	8e-05	0.000308	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MMP1—lung cancer	8e-05	0.000308	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—HRAS—lung cancer	7.91e-05	0.000304	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6—lung cancer	7.86e-05	0.000302	CbGpPWpGaD
Procaine—BCHE—Metabolism—ENO2—lung cancer	7.84e-05	0.000302	CbGpPWpGaD
Procaine—BCHE—Metabolism—HPGDS—lung cancer	7.84e-05	0.000302	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPP2R1B—lung cancer	7.8e-05	0.0003	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.69e-05	0.000296	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTT1—lung cancer	7.61e-05	0.000293	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP2A6—lung cancer	7.52e-05	0.000289	CbGpPWpGaD
Procaine—BCHE—Metabolism—GCLC—lung cancer	7.52e-05	0.000289	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.49e-05	0.000288	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—AKT1—lung cancer	7.25e-05	0.000279	CbGpPWpGaD
Procaine—BCHE—Metabolism—ENO1—lung cancer	7.13e-05	0.000274	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.1e-05	0.000273	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.01e-05	0.00027	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CREBBP—lung cancer	6.99e-05	0.000269	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—POMC—lung cancer	6.65e-05	0.000256	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ALB—lung cancer	6.55e-05	0.000252	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP2E1—lung cancer	6.4e-05	0.000246	CbGpPWpGaD
Procaine—BCHE—Metabolism—NQO1—lung cancer	6.32e-05	0.000243	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.19e-05	0.000238	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MMP2—lung cancer	6.19e-05	0.000238	CbGpPWpGaD
Procaine—BCHE—Neuronal System—HRAS—lung cancer	6.18e-05	0.000238	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.14e-05	0.000236	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—HRAS—lung cancer	6.06e-05	0.000233	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—RAF1—lung cancer	5.92e-05	0.000228	CbGpPWpGaD
Procaine—BCHE—Metabolism—STK11—lung cancer	5.7e-05	0.000219	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.35e-05	0.000206	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTP1—lung cancer	5.27e-05	0.000203	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CXCL8—lung cancer	5.14e-05	0.000198	CbGpPWpGaD
Procaine—BCHE—Metabolism—CAT—lung cancer	5.13e-05	0.000197	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.1e-05	0.000196	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCB1—lung cancer	4.99e-05	0.000192	CbGpPWpGaD
Procaine—BCHE—Metabolism—TYMS—lung cancer	4.9e-05	0.000189	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTM1—lung cancer	4.85e-05	0.000186	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP1A1—lung cancer	4.59e-05	0.000177	CbGpPWpGaD
Procaine—BCHE—Metabolism—ERCC2—lung cancer	4.56e-05	0.000175	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOA1—lung cancer	3.94e-05	0.000152	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.77e-05	0.000145	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CG—lung cancer	3.6e-05	0.000138	CbGpPWpGaD
Procaine—BCHE—Metabolism—POMC—lung cancer	3.43e-05	0.000132	CbGpPWpGaD
Procaine—BCHE—Metabolism—CREBBP—lung cancer	3.34e-05	0.000128	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CD—lung cancer	3.16e-05	0.000122	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALB—lung cancer	3.12e-05	0.00012	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CB—lung cancer	2.76e-05	0.000106	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTGS2—lung cancer	2.73e-05	0.000105	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTEN—lung cancer	2.38e-05	9.17e-05	CbGpPWpGaD
Procaine—BCHE—Metabolism—EP300—lung cancer	2.27e-05	8.74e-05	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3CA—lung cancer	1.68e-05	6.47e-05	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKT1—lung cancer	1.37e-05	5.28e-05	CbGpPWpGaD
